Full name
SYMA - MED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice activities
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
72.11.Z - Research and experimental development on biotechnology
82.11.Z - Office administrative service activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.21.Z - General medical practice activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 48,6 | 34,4 | 95,1 | 176,4 |
EBITDA | 3,1 | -7,9 | -10,5 | -33,2 |
Short time liabilities | 4,4 | 3,1 | 4,3 | 37,8 |
Equity capital | 82,7 | 114 | 200,6 | 75,9 |
Operating profit (EBIT) | 3,1 | -7,9 | -10,5 | -33,2 |
Assets | 87,1 | 117,1 | 204,8 | 74,9 |
Net profit (loss) | 44,2 | 31,3 | 86,5 | 176,4 |
Cash | 0,1 | 46,3 | 201,6 | 335,8 |
Net income from sale | 0 | 0 | 19,6 | -∞ |
Liabilities and provisions for liabilities | 4,4 | 3,1 | 4,3 | 37,8 |
Working assets | 86,1 | 116,1 | 203,8 | 75,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 53,5 | 27,5 | 43,1 | 15,6 |
Equity capital to total assets | 95 | 97,4 | 97,9 | 0,5 |
Gross profit margin | 485,1 | -987,3 | ||
EBITDA Margin | -53,6 | 30 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 79 | -2 147 483 569 |
Current financial liquidity indicator | 19.684675216674805 | 37.51035690307617 | 47.77081298828125 | 10,3 |
Net dept to EBITDA | -0.04432588070631027 | 5.868844509124756 | 19.202346801757812 | 13,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane